AR and prostate carcinoma: Prostate cancer cells are characterized by a hybrid glycolytic/oxidative phosphorylation (OXPHOS) phenotype determined by androgen receptor (AR) signaling that may stimulate the AMPK-PGC1α cascade [45,46,47].